Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

The development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein that decorates the viral surface. A version of the spike ectodomain that includes two proline substitutions (S-2P) and stabilizes the prefus...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 369; no. 6510; pp. 1501 - 1505
Main Authors Hsieh, Ching-Lin, Goldsmith, Jory A., Schaub, Jeffrey M., DiVenere, Andrea M., Kuo, Hung-Che, Javanmardi, Kamyab, Le, Kevin C., Wrapp, Daniel, Lee, Alison G., Liu, Yutong, Chou, Chia-Wei, Byrne, Patrick O., Hjorth, Christy K., Johnson, Nicole V., Ludes-Meyers, John, Nguyen, Annalee W., Park, Juyeon, Wang, Nianshuang, Amengor, Dzifa, Lavinder, Jason J., Ippolito, Gregory C., Maynard, Jennifer A., Finkelstein, Ilya J., McLellan, Jason S.
Format Journal Article
LanguageEnglish
Published United States The American Association for the Advancement of Science 18.09.2020
American Association for the Advancement of Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein that decorates the viral surface. A version of the spike ectodomain that includes two proline substitutions (S-2P) and stabilizes the prefusion conformation has been used to determine high-resolution structures. However, even S-2P is unstable and difficult to produce in mammalian cells. Hsieh et al. characterized many individual and combined structure-guided substitutions and identified a variant, named HexaPro, that retains the prefusion conformation but shows higher expression than S-2P and can also withstand heating and freezing. This version of the protein is likely to be useful in the development of vaccines and diagnostics. Science , this issue p. 1501 The design of stabilizing mutations in the SARS-CoV-2 spike protein allows for high-yield production of a critical vaccine antigen. The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo–electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
AbstractList The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo-electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo-electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Stabilizing the prefusion SARS-CoV-2 spikeThe development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein that decorates the viral surface. A version of the spike ectodomain that includes two proline substitutions (S-2P) and stabilizes the prefusion conformation has been used to determine high-resolution structures. However, even S-2P is unstable and difficult to produce in mammalian cells. Hsieh et al. characterized many individual and combined structure-guided substitutions and identified a variant, named HexaPro, that retains the prefusion conformation but shows higher expression than S-2P and can also withstand heating and freezing. This version of the protein is likely to be useful in the development of vaccines and diagnostics.Science, this issue p. 1501The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo–electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein that decorates the viral surface. A version of the spike ectodomain that includes two proline substitutions (S-2P) and stabilizes the prefusion conformation has been used to determine high-resolution structures. However, even S-2P is unstable and difficult to produce in mammalian cells. Hsieh et al. characterized many individual and combined structure-guided substitutions and identified a variant, named HexaPro, that retains the prefusion conformation but shows higher expression than S-2P and can also withstand heating and freezing. This version of the protein is likely to be useful in the development of vaccines and diagnostics. Science , this issue p. 1501 The design of stabilizing mutations in the SARS-CoV-2 spike protein allows for high-yield production of a critical vaccine antigen. The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo–electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The COVID-19 pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. Here, we characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting ~10-fold higher expression than its parental construct and the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A 3.2 Å-resolution cryo-EM structure of HexaPro confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for SARS-CoV-2.
The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo-electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Author Schaub, Jeffrey M.
DiVenere, Andrea M.
Javanmardi, Kamyab
Lee, Alison G.
Hjorth, Christy K.
Maynard, Jennifer A.
Ippolito, Gregory C.
Nguyen, Annalee W.
Wang, Nianshuang
Liu, Yutong
Park, Juyeon
Finkelstein, Ilya J.
Goldsmith, Jory A.
Wrapp, Daniel
Byrne, Patrick O.
Lavinder, Jason J.
Johnson, Nicole V.
McLellan, Jason S.
Chou, Chia-Wei
Hsieh, Ching-Lin
Kuo, Hung-Che
Ludes-Meyers, John
Amengor, Dzifa
Le, Kevin C.
Author_xml – sequence: 1
  givenname: Ching-Lin
  orcidid: 0000-0002-3665-5717
  surname: Hsieh
  fullname: Hsieh, Ching-Lin
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 2
  givenname: Jory A.
  surname: Goldsmith
  fullname: Goldsmith, Jory A.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 3
  givenname: Jeffrey M.
  orcidid: 0000-0002-1130-2675
  surname: Schaub
  fullname: Schaub, Jeffrey M.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 4
  givenname: Andrea M.
  surname: DiVenere
  fullname: DiVenere, Andrea M.
  organization: Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 5
  givenname: Hung-Che
  surname: Kuo
  fullname: Kuo, Hung-Che
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 6
  givenname: Kamyab
  surname: Javanmardi
  fullname: Javanmardi, Kamyab
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 7
  givenname: Kevin C.
  orcidid: 0000-0001-5098-7737
  surname: Le
  fullname: Le, Kevin C.
  organization: Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 8
  givenname: Daniel
  orcidid: 0000-0002-0538-9647
  surname: Wrapp
  fullname: Wrapp, Daniel
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 9
  givenname: Alison G.
  surname: Lee
  fullname: Lee, Alison G.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 10
  givenname: Yutong
  orcidid: 0000-0003-0626-8094
  surname: Liu
  fullname: Liu, Yutong
  organization: Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 11
  givenname: Chia-Wei
  orcidid: 0000-0001-9618-338X
  surname: Chou
  fullname: Chou, Chia-Wei
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 12
  givenname: Patrick O.
  orcidid: 0000-0002-6462-8951
  surname: Byrne
  fullname: Byrne, Patrick O.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 13
  givenname: Christy K.
  surname: Hjorth
  fullname: Hjorth, Christy K.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 14
  givenname: Nicole V.
  orcidid: 0000-0003-4351-125X
  surname: Johnson
  fullname: Johnson, Nicole V.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 15
  givenname: John
  surname: Ludes-Meyers
  fullname: Ludes-Meyers, John
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 16
  givenname: Annalee W.
  orcidid: 0000-0003-1268-7164
  surname: Nguyen
  fullname: Nguyen, Annalee W.
  organization: Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 17
  givenname: Juyeon
  orcidid: 0000-0001-9549-4645
  surname: Park
  fullname: Park, Juyeon
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 18
  givenname: Nianshuang
  surname: Wang
  fullname: Wang, Nianshuang
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 19
  givenname: Dzifa
  orcidid: 0000-0001-5705-3259
  surname: Amengor
  fullname: Amengor, Dzifa
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
– sequence: 20
  givenname: Jason J.
  orcidid: 0000-0001-6044-1332
  surname: Lavinder
  fullname: Lavinder, Jason J.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA., Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 21
  givenname: Gregory C.
  orcidid: 0000-0002-7565-7002
  surname: Ippolito
  fullname: Ippolito, Gregory C.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA., Department of Oncology, Dell Medical School, University of Texas, Austin, TX 78712, USA
– sequence: 22
  givenname: Jennifer A.
  orcidid: 0000-0002-0363-8486
  surname: Maynard
  fullname: Maynard, Jennifer A.
  organization: Department of Chemical Engineering, University of Texas, Austin, TX 78712, USA
– sequence: 23
  givenname: Ilya J.
  orcidid: 0000-0002-9371-2431
  surname: Finkelstein
  fullname: Finkelstein, Ilya J.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA., Center for Systems and Synthetic Biology, University of Texas, Austin, TX 78712, USA
– sequence: 24
  givenname: Jason S.
  orcidid: 0000-0003-3991-542X
  surname: McLellan
  fullname: McLellan, Jason S.
  organization: Department of Molecular Biosciences, University of Texas, Austin, TX 78712, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32703906$$D View this record in MEDLINE/PubMed
BookMark eNp1UUtLAzEYDKJofZy9ScGLl9Vvk022exGl-AJBsOo1ZJNvNbpNarIr6K830lZU8JIc5pHJzCZZdd4hIbs5HOY5FUdRW3QaD1VtYETFChnkUPGsosBWyQCAiWwEJd8gmzE-AySsYutkg9ESWAViQE4mXeh11wfMahXRDA1G--iGvhnOAjZ9tN5lsVO1be1Hgient5Ns7B8yOowz-4Jxm6w1qo24s7i3yP352d34Mru-ubgan15nmue8S6dWXIxM2RisABUoxhCRF2BYI3hVQ6FZoShWDR9pI1jBmMgNgG4MLahmW-R47jvr6ykaja4LqpWzYKcqvEuvrPyNOPskH_2bLAugguXJ4GBhEPxrj7GTUxs1tq1y6Pso0yslA15xlqj7f6jPvg8ufe-LJXhJaSESa-9nou8oy3ITgc8JOvgYU5tS2051qdEU0LYyB_k1olyMKBcjJt3RH93S-j_FJ4yxof8
CitedBy_id crossref_primary_10_1002_ange_202412294
crossref_primary_10_1016_j_ymthe_2024_12_055
crossref_primary_10_1038_s41467_024_52808_2
crossref_primary_10_1021_acsomega_4c03285
crossref_primary_10_1126_science_abn1900
crossref_primary_10_1016_j_micpath_2021_104832
crossref_primary_10_1093_pnasnexus_pgad403
crossref_primary_10_3390_pr8121539
crossref_primary_10_15252_embr_202154199
crossref_primary_10_3390_vaccines9050498
crossref_primary_10_3389_fimmu_2021_781280
crossref_primary_10_1016_j_celrep_2022_110368
crossref_primary_10_1371_journal_ppat_1011308
crossref_primary_10_3389_fimmu_2022_837443
crossref_primary_10_1371_journal_ppat_1011545
crossref_primary_10_1007_s10875_021_01174_5
crossref_primary_10_1128_jvi_00416_24
crossref_primary_10_1016_j_bios_2023_115202
crossref_primary_10_1038_s41541_022_00472_2
crossref_primary_10_1107_S2052252521009076
crossref_primary_10_1016_j_jmb_2021_167332
crossref_primary_10_1063_5_0022211
crossref_primary_10_1016_j_ymeth_2021_03_007
crossref_primary_10_1016_j_jmb_2022_167637
crossref_primary_10_1016_j_cell_2022_01_011
crossref_primary_10_3389_fimmu_2022_838780
crossref_primary_10_3390_vaccines11091427
crossref_primary_10_1016_j_immuni_2022_12_005
crossref_primary_10_1093_abt_tbaa028
crossref_primary_10_1126_science_adr6006
crossref_primary_10_3390_v14020370
crossref_primary_10_3390_vaccines13030315
crossref_primary_10_1016_j_cell_2024_12_015
crossref_primary_10_1016_j_ebiom_2022_103902
crossref_primary_10_1126_science_abq0203
crossref_primary_10_2139_ssrn_4102635
crossref_primary_10_1016_j_cell_2021_06_021
crossref_primary_10_1038_s41541_022_00528_3
crossref_primary_10_1021_acs_chemrev_1c00937
crossref_primary_10_1021_acsomega_1c03558
crossref_primary_10_1126_science_abe0075
crossref_primary_10_1016_j_celrep_2024_114265
crossref_primary_10_3390_vaccines10030407
crossref_primary_10_1016_j_jvacx_2021_100126
crossref_primary_10_1016_j_yjsbx_2025_100123
crossref_primary_10_1093_protein_gzac002
crossref_primary_10_1016_j_immuni_2022_04_003
crossref_primary_10_1126_science_abe3354
crossref_primary_10_1016_j_xcrm_2024_101668
crossref_primary_10_1146_annurev_med_042420_112725
crossref_primary_10_1016_j_jbc_2021_101238
crossref_primary_10_1021_acscentsci_0c01056
crossref_primary_10_1016_j_celrep_2022_111004
crossref_primary_10_1016_j_isci_2023_107085
crossref_primary_10_1021_acs_jcim_1c00766
crossref_primary_10_1016_j_celrep_2022_110561
crossref_primary_10_1016_j_celrep_2023_112621
crossref_primary_10_1126_science_abi4711
crossref_primary_10_1128_mBio_01002_21
crossref_primary_10_1021_jacs_3c04966
crossref_primary_10_1038_s41541_022_00508_7
crossref_primary_10_7774_cevr_2022_11_3_285
crossref_primary_10_1021_acssynbio_0c00566
crossref_primary_10_1093_bib_bbaa362
crossref_primary_10_1093_infdis_jiab349
crossref_primary_10_1126_science_abq3773
crossref_primary_10_1016_j_jbc_2021_101202
crossref_primary_10_1038_s41586_021_03530_2
crossref_primary_10_1038_s41421_023_00534_2
crossref_primary_10_7554_eLife_73027
crossref_primary_10_3389_fmicb_2022_802098
crossref_primary_10_1016_j_pbiomolbio_2023_02_004
crossref_primary_10_1016_j_heliyon_2024_e34492
crossref_primary_10_3390_ijms23042172
crossref_primary_10_1021_acs_analchem_2c00554
crossref_primary_10_1016_j_ymthe_2024_02_011
crossref_primary_10_1126_science_abq2679
crossref_primary_10_1038_s41467_022_32232_0
crossref_primary_10_1098_rsob_230252
crossref_primary_10_1126_sciadv_adh1655
crossref_primary_10_1016_j_vaccine_2022_04_078
crossref_primary_10_1038_s41392_021_00712_2
crossref_primary_10_3390_vaccines10111926
crossref_primary_10_1093_cid_ciac077
crossref_primary_10_1038_s41586_021_03258_z
crossref_primary_10_1016_j_isci_2024_110354
crossref_primary_10_1371_journal_pbio_3001237
crossref_primary_10_1016_j_jgg_2021_02_006
crossref_primary_10_1016_j_isci_2022_104549
crossref_primary_10_1038_s41467_021_27097_8
crossref_primary_10_1038_s41598_021_93996_x
crossref_primary_10_1073_pnas_2201616119
crossref_primary_10_1016_j_meegid_2024_105626
crossref_primary_10_3724_zdxbyxb_2023_0101
crossref_primary_10_1021_acsnano_2c06350
crossref_primary_10_1126_science_abl8506
crossref_primary_10_3390_gastroent14040032
crossref_primary_10_3389_fimmu_2023_1138629
crossref_primary_10_7554_eLife_75228
crossref_primary_10_1371_journal_ppat_1011728
crossref_primary_10_1038_s41392_023_01561_x
crossref_primary_10_1016_j_comptc_2023_114049
crossref_primary_10_1016_j_dcit_2024_100017
crossref_primary_10_3390_vaccines11091451
crossref_primary_10_1038_s41467_023_38251_9
crossref_primary_10_1038_s42003_025_07769_7
crossref_primary_10_3390_cimb44070195
crossref_primary_10_1146_annurev_biophys_102620_080956
crossref_primary_10_3390_v14051049
crossref_primary_10_1038_s41590_021_01068_z
crossref_primary_10_1038_s41392_020_00352_y
crossref_primary_10_1016_j_celrep_2022_111299
crossref_primary_10_1371_journal_pone_0306457
crossref_primary_10_1038_s41467_021_27610_z
crossref_primary_10_1038_s41594_022_00735_5
crossref_primary_10_1126_science_abf6840
crossref_primary_10_1128_jvi_01596_22
crossref_primary_10_1002_bit_27615
crossref_primary_10_3390_v16091458
crossref_primary_10_1128_mBio_01908_21
crossref_primary_10_1371_journal_pone_0259703
crossref_primary_10_1021_acs_analchem_2c01221
crossref_primary_10_1016_j_immuni_2021_08_013
crossref_primary_10_1002_biot_202100678
crossref_primary_10_3390_pharmaceutics13111759
crossref_primary_10_1016_j_celrep_2023_112421
crossref_primary_10_14324_111_444_ucloe_000020
crossref_primary_10_2174_1570159X20666220627165846
crossref_primary_10_3390_vaccines12091007
crossref_primary_10_3390_vaccines9070708
crossref_primary_10_1038_s44298_024_00043_3
crossref_primary_10_3390_ijms25105499
crossref_primary_10_1016_j_immuni_2021_08_016
crossref_primary_10_1016_j_immuni_2021_08_015
crossref_primary_10_3390_v13091743
crossref_primary_10_3390_ijms231911542
crossref_primary_10_1038_s41421_021_00331_9
crossref_primary_10_3390_md18110543
crossref_primary_10_1016_j_celrep_2021_109929
crossref_primary_10_3390_v14050854
crossref_primary_10_1038_s41422_022_00706_x
crossref_primary_10_1038_s41467_024_45274_3
crossref_primary_10_1073_pnas_2404892121
crossref_primary_10_1038_s42003_025_07827_0
crossref_primary_10_1186_s12916_021_02228_6
crossref_primary_10_1038_s41467_024_50976_9
crossref_primary_10_1016_j_scib_2023_11_024
crossref_primary_10_1016_j_jiph_2023_05_004
crossref_primary_10_1080_19420862_2021_2002236
crossref_primary_10_1007_s12038_021_00226_7
crossref_primary_10_1007_s11684_023_1034_6
crossref_primary_10_1038_s41467_023_38965_w
crossref_primary_10_1128_jvi_00922_23
crossref_primary_10_1186_s12903_024_03980_w
crossref_primary_10_3389_fmicb_2022_1041338
crossref_primary_10_1002_anie_202100316
crossref_primary_10_1080_07391102_2021_1933594
crossref_primary_10_3390_v16020223
crossref_primary_10_4014_jmb_2411_11001
crossref_primary_10_1038_s41596_021_00623_0
crossref_primary_10_1016_j_isci_2022_104914
crossref_primary_10_3390_ijms25094955
crossref_primary_10_15252_emmm_202215888
crossref_primary_10_1016_j_str_2023_12_013
crossref_primary_10_1038_s41586_021_03676_z
crossref_primary_10_1016_j_celrep_2024_114922
crossref_primary_10_5802_crbiol_35
crossref_primary_10_1111_pbi_13908
crossref_primary_10_1016_j_immuni_2021_09_011
crossref_primary_10_1093_cvr_cvac097
crossref_primary_10_1126_sciadv_abj8065
crossref_primary_10_3390_v13102076
crossref_primary_10_1021_acs_jcim_2c00124
crossref_primary_10_1038_s41467_021_24963_3
crossref_primary_10_3390_vaccines10081172
crossref_primary_10_1021_acs_jcim_1c01484
crossref_primary_10_1016_j_celrep_2023_113553
crossref_primary_10_1021_acsnano_4c11652
crossref_primary_10_1016_j_actbio_2021_12_022
crossref_primary_10_3389_fimmu_2023_1231274
crossref_primary_10_1099_jgv_0_001947
crossref_primary_10_1126_science_abm8143
crossref_primary_10_1038_s41421_022_00463_6
crossref_primary_10_3389_fimmu_2021_824728
crossref_primary_10_3390_vaccines9030296
crossref_primary_10_1016_j_isci_2022_104739
crossref_primary_10_1016_j_heliyon_2025_e42533
crossref_primary_10_3390_vaccines9101052
crossref_primary_10_3389_fimmu_2023_1291972
crossref_primary_10_1016_j_chom_2021_12_010
crossref_primary_10_1080_13543776_2021_1945581
crossref_primary_10_1016_j_celrep_2023_113542
crossref_primary_10_1002_advs_202304818
crossref_primary_10_1093_glycob_cwab063
crossref_primary_10_3390_v15010139
crossref_primary_10_5802_crbiol_53
crossref_primary_10_3389_fimmu_2022_878812
crossref_primary_10_1016_j_jbc_2023_102954
crossref_primary_10_1016_j_sbi_2022_102385
crossref_primary_10_1016_j_sbi_2023_102664
crossref_primary_10_1371_journal_pbio_3002174
crossref_primary_10_1093_infdis_jiab161
crossref_primary_10_3390_vaccines12060561
crossref_primary_10_1038_s41598_022_07485_w
crossref_primary_10_1016_j_crmeth_2024_100934
crossref_primary_10_1016_j_omtn_2023_01_008
crossref_primary_10_1107_S2059798323005041
crossref_primary_10_1016_j_cell_2021_07_025
crossref_primary_10_1016_j_jviromet_2021_114222
crossref_primary_10_1038_s41541_024_00982_1
crossref_primary_10_1126_sciimmunol_adk5845
crossref_primary_10_3390_vaccines9070734
crossref_primary_10_1002_mco2_460
crossref_primary_10_1016_j_isci_2023_107882
crossref_primary_10_3389_fimmu_2023_941281
crossref_primary_10_1016_j_jviromet_2024_115027
crossref_primary_10_1038_s41467_021_26499_y
crossref_primary_10_1038_s41541_021_00417_1
crossref_primary_10_3390_vaccines12030248
crossref_primary_10_1038_s41467_023_37417_9
crossref_primary_10_1084_jem_20220826
crossref_primary_10_1038_s41564_021_00972_2
crossref_primary_10_1021_acs_analchem_1c01772
crossref_primary_10_1016_j_celrep_2021_109760
crossref_primary_10_7554_eLife_83710
crossref_primary_10_1016_j_chom_2021_03_005
crossref_primary_10_3389_fnume_2022_1033697
crossref_primary_10_1126_science_abi7994
crossref_primary_10_3389_fimmu_2020_576622
crossref_primary_10_1126_sciadv_abn4188
crossref_primary_10_1093_ofid_ofae626
crossref_primary_10_1177_00220345221102310
crossref_primary_10_1002_cti2_1264
crossref_primary_10_1128_mbio_02477_23
crossref_primary_10_1128_jvi_00433_23
crossref_primary_10_1016_j_celrep_2022_110812
crossref_primary_10_1038_s41467_024_45404_x
crossref_primary_10_1038_s42003_025_07763_z
crossref_primary_10_1002_ange_202100316
crossref_primary_10_1016_j_celrep_2023_112014
crossref_primary_10_1038_s41421_022_00435_w
crossref_primary_10_1038_s41467_021_25478_7
crossref_primary_10_3389_fimmu_2021_809244
crossref_primary_10_1016_j_antiviral_2023_105738
crossref_primary_10_1021_acs_jpcb_2c05470
crossref_primary_10_1016_j_chom_2024_10_016
crossref_primary_10_1016_j_ebiom_2022_104203
crossref_primary_10_1016_j_bpj_2021_11_009
crossref_primary_10_1002_aic_17440
crossref_primary_10_1371_journal_ppat_1012291
crossref_primary_10_1016_j_celrep_2021_109784
crossref_primary_10_1016_j_crmeth_2024_100856
crossref_primary_10_1002_cti2_1476
crossref_primary_10_1126_science_abg9175
crossref_primary_10_1016_j_vaccine_2023_08_054
crossref_primary_10_3390_v13010109
crossref_primary_10_1186_s40580_024_00434_5
crossref_primary_10_3390_vaccines13010002
crossref_primary_10_1038_s41467_025_55824_y
crossref_primary_10_1038_s41587_023_01763_2
crossref_primary_10_1126_sciadv_adg5301
crossref_primary_10_3390_vaccines13010007
crossref_primary_10_1016_j_cell_2024_09_026
crossref_primary_10_3390_v13020332
crossref_primary_10_1038_s41467_022_28324_6
crossref_primary_10_1016_j_chom_2021_04_005
crossref_primary_10_1128_mbio_03227_21
crossref_primary_10_1038_s41565_024_01655_9
crossref_primary_10_1021_acsinfecdis_1c00433
crossref_primary_10_1038_s41541_023_00662_6
crossref_primary_10_1038_s41421_022_00381_7
crossref_primary_10_1016_j_immuni_2022_07_015
crossref_primary_10_1038_s41596_021_00554_w
crossref_primary_10_3389_fimmu_2022_888794
crossref_primary_10_1016_j_antiviral_2023_105548
crossref_primary_10_3390_ma13235362
crossref_primary_10_1126_science_abh2315
crossref_primary_10_1016_j_ejmech_2025_117450
crossref_primary_10_1016_j_vaccine_2023_08_037
crossref_primary_10_1128_jvi_01448_23
crossref_primary_10_1016_j_xcrm_2023_101305
crossref_primary_10_1038_s41586_020_2798_3
crossref_primary_10_3389_fbioe_2022_1052436
crossref_primary_10_1038_s41598_022_16914_9
crossref_primary_10_1021_acs_jpcb_0c10637
crossref_primary_10_1371_journal_pntd_0009374
crossref_primary_10_3390_medicina59030507
crossref_primary_10_1016_j_antiviral_2023_105778
crossref_primary_10_1002_cti2_1269
crossref_primary_10_1038_s41467_021_25589_1
crossref_primary_10_3389_fmolb_2023_1288686
crossref_primary_10_1080_22221751_2021_1887767
crossref_primary_10_1128_jvi_01773_23
crossref_primary_10_1128_spectrum_00959_24
crossref_primary_10_3389_fbioe_2021_779359
crossref_primary_10_1002_jmv_28687
crossref_primary_10_1039_D4CP01372G
crossref_primary_10_1016_j_apsb_2024_12_003
crossref_primary_10_1038_s41587_022_01232_2
crossref_primary_10_1128_jvi_01954_24
crossref_primary_10_1186_s12951_025_03243_y
crossref_primary_10_1016_j_ebiom_2022_104248
crossref_primary_10_2139_ssrn_4120772
crossref_primary_10_1128_jvi_01623_23
crossref_primary_10_1038_s41419_024_06802_7
crossref_primary_10_1126_sciadv_adg2248
crossref_primary_10_1016_j_vaccine_2023_09_059
crossref_primary_10_1371_journal_ppat_1012493
crossref_primary_10_3389_fimmu_2025_1535261
crossref_primary_10_1016_j_vaccine_2025_126880
crossref_primary_10_1016_j_antiviral_2024_105820
crossref_primary_10_1126_scisignal_adn3785
crossref_primary_10_15252_emmm_202114544
crossref_primary_10_1021_acs_jpcb_4c01341
crossref_primary_10_3390_v15020558
crossref_primary_10_1073_pnas_2310469121
crossref_primary_10_1016_j_cell_2021_09_015
crossref_primary_10_1038_s41421_022_00431_0
crossref_primary_10_1021_acscentsci_3c00887
crossref_primary_10_1084_jem_20220638
crossref_primary_10_3389_fmicb_2023_1210898
crossref_primary_10_1002_bit_28387
crossref_primary_10_3390_microorganisms11092347
crossref_primary_10_1016_j_apsb_2022_11_026
crossref_primary_10_1016_j_str_2024_06_012
crossref_primary_10_1016_j_isci_2023_106955
crossref_primary_10_1016_j_celrep_2023_113194
crossref_primary_10_1016_j_xcrm_2022_100528
crossref_primary_10_1016_j_cell_2024_07_052
crossref_primary_10_1038_s41467_023_37786_1
crossref_primary_10_3390_life12010057
crossref_primary_10_1016_j_virol_2025_110412
crossref_primary_10_1016_j_ebiom_2022_104297
crossref_primary_10_1016_j_xcrm_2024_101850
crossref_primary_10_1016_j_cell_2022_03_044
crossref_primary_10_3390_vaccines12010005
crossref_primary_10_1038_s41467_021_27063_4
crossref_primary_10_3390_vaccines8040746
crossref_primary_10_1016_j_copbio_2022_102821
crossref_primary_10_1128_spectrum_01034_22
crossref_primary_10_1038_s41541_021_00390_9
crossref_primary_10_1186_s11658_022_00341_9
crossref_primary_10_1016_j_mucimm_2024_01_004
crossref_primary_10_3390_polym14153014
crossref_primary_10_1126_scitranslmed_abo2847
crossref_primary_10_1016_j_chroma_2022_463424
crossref_primary_10_3390_vaccines11010012
crossref_primary_10_1016_j_celrep_2021_110112
crossref_primary_10_1038_s41467_023_44265_0
crossref_primary_10_1016_j_ymthe_2022_09_010
crossref_primary_10_3390_v15122405
crossref_primary_10_1016_j_antiviral_2023_105576
crossref_primary_10_3390_vaccines12080914
crossref_primary_10_1021_acs_chemrev_1c01062
crossref_primary_10_1371_journal_ppat_1011123
crossref_primary_10_3390_v14030562
crossref_primary_10_1016_j_xcrm_2022_100780
crossref_primary_10_1021_acs_jctc_3c00513
crossref_primary_10_1126_science_abq0839
crossref_primary_10_1038_s41467_022_35642_2
crossref_primary_10_1016_j_cell_2024_06_016
crossref_primary_10_3389_fimmu_2024_1380697
crossref_primary_10_1016_j_vaccine_2024_01_065
crossref_primary_10_1126_science_abe6230
crossref_primary_10_1016_j_molcel_2022_03_028
crossref_primary_10_1177_1721727X221095382
crossref_primary_10_1016_j_celrep_2022_111528
crossref_primary_10_1038_s41467_022_30878_4
crossref_primary_10_1038_s41594_020_00547_5
crossref_primary_10_3390_ijms24076642
crossref_primary_10_1016_j_scib_2023_03_027
crossref_primary_10_1038_s41541_025_01090_4
crossref_primary_10_1016_j_jmb_2023_168113
crossref_primary_10_1038_s41467_022_34297_3
crossref_primary_10_7554_eLife_75720
crossref_primary_10_1021_acs_molpharmaceut_2c00860
crossref_primary_10_1038_s41541_021_00292_w
crossref_primary_10_1038_s41598_023_40741_1
crossref_primary_10_3390_ijms25084281
crossref_primary_10_1002_jia2_25797
crossref_primary_10_1038_s41586_023_06761_7
crossref_primary_10_1111_1348_0421_13165
crossref_primary_10_1016_j_crimmu_2022_10_001
crossref_primary_10_1038_s41467_022_28882_9
crossref_primary_10_1038_s41467_024_48059_w
crossref_primary_10_1039_D2CC04711J
crossref_primary_10_1002_pmic_202300143
crossref_primary_10_1016_j_ebiom_2025_105615
crossref_primary_10_1016_j_tim_2023_03_001
crossref_primary_10_1371_journal_ppat_1011584
crossref_primary_10_1016_j_jmb_2021_167093
crossref_primary_10_1016_j_chom_2021_02_002
crossref_primary_10_1371_journal_pbio_3001967
crossref_primary_10_1038_s41541_023_00707_w
crossref_primary_10_1038_s41541_021_00324_5
crossref_primary_10_3390_v14061262
crossref_primary_10_1016_j_jmb_2020_166748
crossref_primary_10_1016_j_yjsbx_2020_100038
crossref_primary_10_1038_s41577_020_00480_0
crossref_primary_10_3390_biomedicines10030630
crossref_primary_10_1016_j_chom_2022_10_003
crossref_primary_10_1038_s41594_024_01438_9
crossref_primary_10_1038_s41598_023_43661_2
crossref_primary_10_1172_jci_insight_148855
crossref_primary_10_1128_msystems_00928_22
crossref_primary_10_1016_j_celrep_2021_109353
crossref_primary_10_1016_j_pbiomolbio_2021_05_007
crossref_primary_10_1093_bib_bbae468
crossref_primary_10_3390_vaccines10020236
crossref_primary_10_1016_j_vaccine_2024_126511
crossref_primary_10_1002_btm2_10650
crossref_primary_10_3390_biom12070964
crossref_primary_10_1021_acs_biochem_1c00279
crossref_primary_10_1126_sciadv_abe8065
crossref_primary_10_1016_j_saa_2021_120269
crossref_primary_10_1038_s41467_023_40960_0
crossref_primary_10_1016_j_isci_2022_105596
crossref_primary_10_1021_acs_jcim_1c00857
crossref_primary_10_1126_sciadv_add7221
crossref_primary_10_1038_s41573_024_01041_z
crossref_primary_10_1002_ardp_202400307
crossref_primary_10_1128_mbio_00067_24
crossref_primary_10_1021_acs_jpclett_4c03654
crossref_primary_10_1038_s41592_022_01436_z
crossref_primary_10_1002_eji_202350408
crossref_primary_10_1021_acscentsci_2c01349
crossref_primary_10_1128_jvi_00286_23
crossref_primary_10_1016_j_celrep_2022_111964
crossref_primary_10_1016_j_coi_2021_07_003
crossref_primary_10_3389_fpls_2021_798822
crossref_primary_10_1038_s41467_024_44830_1
crossref_primary_10_1016_j_str_2024_08_022
crossref_primary_10_1038_s41590_024_01951_5
crossref_primary_10_1016_j_sbi_2022_102402
crossref_primary_10_3390_vaccines12101089
crossref_primary_10_1038_s41541_024_00870_8
crossref_primary_10_1016_j_xcrm_2024_101577
crossref_primary_10_1126_science_abn8652
crossref_primary_10_1016_j_cytogfr_2020_11_001
crossref_primary_10_1146_annurev_med_012621_102252
crossref_primary_10_1038_s41541_023_00742_7
crossref_primary_10_1016_j_jia_2024_07_024
crossref_primary_10_1038_s41467_022_35781_6
crossref_primary_10_1126_science_abg5268
crossref_primary_10_1002_jmv_29163
crossref_primary_10_1128_jvi_01673_22
crossref_primary_10_1038_s41586_024_08121_5
crossref_primary_10_1038_s41586_021_03925_1
crossref_primary_10_1126_science_abm5561
crossref_primary_10_1038_s41579_022_00841_7
crossref_primary_10_1038_s41467_022_33209_9
crossref_primary_10_1038_s41541_021_00410_8
crossref_primary_10_1038_s41589_022_01193_2
crossref_primary_10_1128_mbio_02928_23
crossref_primary_10_1016_j_jconrel_2023_02_011
crossref_primary_10_1021_acschemneuro_2c00610
crossref_primary_10_1038_s44320_025_00093_6
crossref_primary_10_1038_s41467_022_31300_9
crossref_primary_10_1021_acsomega_1c02336
crossref_primary_10_3389_fimmu_2022_896310
crossref_primary_10_1002_jmv_29183
crossref_primary_10_1080_21645515_2024_2315709
crossref_primary_10_1128_jvi_01157_23
crossref_primary_10_1371_journal_ppat_1012724
crossref_primary_10_1002_ueg2_12103
crossref_primary_10_1371_journal_ppat_1012726
crossref_primary_10_1016_j_ebiom_2022_103841
crossref_primary_10_1016_j_hsr_2023_100112
crossref_primary_10_7554_eLife_61312
crossref_primary_10_1016_j_ymthe_2020_10_004
crossref_primary_10_1016_j_isci_2022_104449
crossref_primary_10_1038_s41598_024_56293_x
crossref_primary_10_1172_JCI168080
crossref_primary_10_1093_jalm_jfab080
crossref_primary_10_1080_22221751_2024_2389115
crossref_primary_10_1371_journal_ppat_1012713
crossref_primary_10_1080_21645515_2023_2174755
crossref_primary_10_3390_v13101942
crossref_primary_10_1126_sciadv_ado6280
crossref_primary_10_3389_fimmu_2022_863831
crossref_primary_10_1021_acsomega_3c06811
crossref_primary_10_3390_v14081816
crossref_primary_10_1002_jmv_26926
crossref_primary_10_1038_s41467_021_21037_2
crossref_primary_10_1016_j_cocis_2021_101468
crossref_primary_10_1021_acs_jpclett_1c01415
crossref_primary_10_1073_pnas_2101918118
crossref_primary_10_3390_vaccines10040578
crossref_primary_10_1080_17460794_2024_2403253
crossref_primary_10_1038_s41586_020_2852_1
crossref_primary_10_1016_j_xcrm_2021_100450
crossref_primary_10_1016_j_celrep_2021_110156
crossref_primary_10_1371_journal_ppat_1012704
crossref_primary_10_1016_j_molcel_2023_05_006
crossref_primary_10_1038_s41541_022_00507_8
crossref_primary_10_3390_ijms26031263
crossref_primary_10_3389_fmolb_2024_1429180
crossref_primary_10_4049_jimmunol_2200297
crossref_primary_10_1016_j_jiph_2024_102473
crossref_primary_10_1016_j_cell_2023_04_024
crossref_primary_10_1038_s41541_022_00571_0
crossref_primary_10_1038_s41421_023_00535_1
crossref_primary_10_1016_j_celrep_2024_115036
crossref_primary_10_1038_s41467_024_45495_6
crossref_primary_10_1002_anie_202412294
crossref_primary_10_1016_j_isci_2023_108086
crossref_primary_10_1039_D2SC00534D
crossref_primary_10_1016_j_nbt_2023_12_004
crossref_primary_10_1080_14760584_2021_1918003
crossref_primary_10_1016_j_immuni_2024_02_016
crossref_primary_10_1016_j_immuni_2024_02_017
crossref_primary_10_1002_pro_4300
crossref_primary_10_1128_mbio_01922_24
crossref_primary_10_1038_s41541_023_00773_0
crossref_primary_10_1016_j_cell_2021_01_050
crossref_primary_10_4049_jimmunol_2300282
crossref_primary_10_1016_j_isci_2023_107120
crossref_primary_10_1016_j_vaccine_2022_07_013
crossref_primary_10_1016_j_chom_2022_07_016
crossref_primary_10_1016_j_celrep_2023_112307
crossref_primary_10_1002_jmv_27132
crossref_primary_10_1038_s41590_024_01944_4
crossref_primary_10_3389_fimmu_2024_1329846
crossref_primary_10_12688_gatesopenres_15270_1
crossref_primary_10_5940_jcrsj_66_109
crossref_primary_10_2139_ssrn_3961037
crossref_primary_10_1126_sciimmunol_abg6916
crossref_primary_10_3390_bios14030113
crossref_primary_10_1038_s42003_024_06951_7
crossref_primary_10_1007_s15010_023_02111_x
crossref_primary_10_1016_j_chom_2020_11_001
crossref_primary_10_1126_scitranslmed_abf1906
crossref_primary_10_1073_pnas_2103154118
crossref_primary_10_15252_embj_2021107985
crossref_primary_10_1128_mBio_02707_20
crossref_primary_10_1126_science_abo2523
crossref_primary_10_1016_j_chom_2020_11_007
crossref_primary_10_3390_vaccines11111641
crossref_primary_10_1016_j_jim_2021_113182
crossref_primary_10_1016_j_coviro_2021_05_005
crossref_primary_10_1021_acs_jpclett_0c02958
crossref_primary_10_3390_act10010002
crossref_primary_10_1038_s41467_022_34961_8
crossref_primary_10_1016_j_str_2024_09_008
crossref_primary_10_3390_ijms23062928
crossref_primary_10_19163_1994_9480_2021_2_78__18_27
crossref_primary_10_3390_ijms22105092
crossref_primary_10_1126_scitranslmed_abn1252
crossref_primary_10_3390_v15102009
crossref_primary_10_1016_j_jmb_2022_167928
crossref_primary_10_1128_jvi_01070_23
crossref_primary_10_1128_jvi_01372_23
crossref_primary_10_1016_j_vaccine_2022_08_049
crossref_primary_10_1016_j_biologicals_2023_101700
crossref_primary_10_3390_cells11071182
crossref_primary_10_1038_s41392_022_00950_y
crossref_primary_10_1038_s41467_023_39278_8
crossref_primary_10_1172_jci_insight_174133
crossref_primary_10_1021_acs_jctc_3c00077
crossref_primary_10_7554_eLife_74060
crossref_primary_10_1016_j_celrep_2021_109822
crossref_primary_10_1038_s41467_023_36761_0
crossref_primary_10_1126_sciimmunol_abp9312
crossref_primary_10_1182_bloodadvances_2021006698
crossref_primary_10_1038_s41586_021_03807_6
crossref_primary_10_1126_sciadv_abq8276
crossref_primary_10_7774_cevr_2024_13_3_202
crossref_primary_10_1128_jvi_01307_24
crossref_primary_10_1093_nar_gkae408
crossref_primary_10_1016_j_isci_2023_108256
crossref_primary_10_7554_eLife_86764_3
crossref_primary_10_1007_s00216_022_04000_y
crossref_primary_10_1007_s11596_021_2453_8
crossref_primary_10_1038_s41392_025_02154_6
crossref_primary_10_1021_acsabm_2c00328
crossref_primary_10_1002_sim_8931
crossref_primary_10_3390_cells10020206
crossref_primary_10_1371_journal_pone_0273097
crossref_primary_10_3390_v13050837
crossref_primary_10_1016_j_biotechadv_2023_108283
crossref_primary_10_1016_j_ebiom_2024_105185
crossref_primary_10_1038_s41467_023_42200_x
crossref_primary_10_3389_fimmu_2025_1488388
crossref_primary_10_1038_s41586_021_03324_6
crossref_primary_10_1360_SSV_2024_0179
crossref_primary_10_1016_j_isci_2025_112082
crossref_primary_10_1126_science_abl6251
crossref_primary_10_1021_acs_jmedchem_3c00576
crossref_primary_10_3389_fimmu_2021_677027
crossref_primary_10_1038_s41467_022_34060_8
crossref_primary_10_1038_s41467_022_28931_3
crossref_primary_10_1038_s41541_023_00755_2
crossref_primary_10_1038_s41467_022_30222_w
crossref_primary_10_1038_s42003_023_04755_9
crossref_primary_10_2139_ssrn_3917167
crossref_primary_10_1038_s41541_022_00493_x
crossref_primary_10_1016_j_celrep_2022_111160
crossref_primary_10_1002_adtp_202000224
crossref_primary_10_1039_D2CP01893D
crossref_primary_10_3390_ijms23062977
crossref_primary_10_1021_jacs_1c00556
crossref_primary_10_1080_21645515_2022_2050123
crossref_primary_10_1002_EXP_20210082
crossref_primary_10_1016_j_isci_2023_108490
crossref_primary_10_1016_j_molcel_2021_11_024
crossref_primary_10_1016_j_cell_2023_06_005
crossref_primary_10_1073_pnas_2220403120
crossref_primary_10_1126_scitranslmed_abi9215
crossref_primary_10_1016_j_celrep_2023_113478
crossref_primary_10_1128_jvi_00480_22
crossref_primary_10_1016_j_ijbiomac_2021_10_172
crossref_primary_10_1038_s41392_022_00954_8
crossref_primary_10_1016_j_cell_2021_03_028
crossref_primary_10_1016_j_cell_2021_03_029
crossref_primary_10_1097_TXD_0000000000001246
crossref_primary_10_3389_fimmu_2021_660198
crossref_primary_10_1002_jmv_27425
crossref_primary_10_1038_s41467_024_45480_z
crossref_primary_10_1016_j_ebiom_2022_104341
crossref_primary_10_1073_pnas_2110105119
crossref_primary_10_1126_science_abh1139
crossref_primary_10_1016_j_antiviral_2022_105370
crossref_primary_10_1038_s41467_024_53033_7
crossref_primary_10_1016_j_coviro_2021_11_011
crossref_primary_10_1038_s41467_023_38435_3
crossref_primary_10_3390_vaccines12080873
crossref_primary_10_3390_pharmaceutics15061766
crossref_primary_10_1021_acscentsci_1c00197
crossref_primary_10_1016_j_immuni_2021_07_008
crossref_primary_10_3390_pathogens12030419
crossref_primary_10_1172_JCI178880
crossref_primary_10_1111_all_15091
crossref_primary_10_1021_acs_chemrev_1c00009
crossref_primary_10_1016_j_celrep_2023_113444
crossref_primary_10_3390_cells10081843
crossref_primary_10_3390_biomedicines11020517
crossref_primary_10_1016_j_cell_2021_04_032
crossref_primary_10_1038_s41577_021_00567_2
crossref_primary_10_1002_advs_202412116
crossref_primary_10_3389_fcimb_2022_979641
crossref_primary_10_3390_v15051143
crossref_primary_10_1007_s00281_023_00996_2
crossref_primary_10_1021_acs_jpcb_1c00395
crossref_primary_10_1038_s41467_020_20321_x
crossref_primary_10_1371_journal_ppat_1012158
crossref_primary_10_1021_acsnano_2c12584
crossref_primary_10_1177_09636897221090259
crossref_primary_10_1016_j_immuni_2022_10_019
crossref_primary_10_1038_s41594_021_00652_z
crossref_primary_10_1016_j_nantod_2022_101730
crossref_primary_10_3389_fmicb_2024_1396894
crossref_primary_10_3390_ijms23084376
crossref_primary_10_1542_peds_2020_018242
crossref_primary_10_3389_fimmu_2021_803647
crossref_primary_10_1126_sciadv_abh1547
crossref_primary_10_1038_s41392_022_00987_z
crossref_primary_10_1371_journal_ppat_1011057
crossref_primary_10_1016_j_nantod_2022_101729
crossref_primary_10_1186_s12985_023_01977_5
crossref_primary_10_3390_vaccines12040343
crossref_primary_10_1371_journal_ppat_1012383
crossref_primary_10_1016_j_antiviral_2023_105656
crossref_primary_10_1038_s41589_022_01059_7
crossref_primary_10_1038_s41467_024_51770_3
crossref_primary_10_1126_sciadv_abn2911
crossref_primary_10_1016_j_cell_2020_10_043
crossref_primary_10_1038_s41467_022_34439_7
crossref_primary_10_1021_acsnano_2c02794
crossref_primary_10_1111_1751_7915_13818
crossref_primary_10_1016_j_celrep_2023_112167
crossref_primary_10_1371_journal_pcbi_1012812
crossref_primary_10_1016_j_antiviral_2025_106082
crossref_primary_10_1002_wnan_1894
crossref_primary_10_1042_BCJ20210798
crossref_primary_10_1016_j_immuni_2023_09_003
crossref_primary_10_3390_v13071320
crossref_primary_10_1038_s41541_021_00393_6
crossref_primary_10_1039_D3CP02042H
crossref_primary_10_7554_eLife_74707
crossref_primary_10_1038_s41467_024_49443_2
crossref_primary_10_3390_v13102106
crossref_primary_10_1016_j_chom_2021_10_003
crossref_primary_10_3390_ijms23031646
crossref_primary_10_1128_Spectrum_00341_21
crossref_primary_10_3390_vaccines8040635
crossref_primary_10_1073_pnas_2413465122
crossref_primary_10_1002_adma_202107781
crossref_primary_10_1038_s41541_022_00586_7
crossref_primary_10_1126_sciadv_adg0330
crossref_primary_10_1126_scitranslmed_adg1855
crossref_primary_10_1126_sciimmunol_adf1421
crossref_primary_10_1021_acs_jcim_3c00778
crossref_primary_10_1016_j_coi_2022_102209
crossref_primary_10_1111_febs_16777
crossref_primary_10_1016_j_smim_2021_101533
crossref_primary_10_1016_j_matt_2025_102006
crossref_primary_10_1007_s00216_023_04533_w
crossref_primary_10_1016_j_vaccine_2024_126680
crossref_primary_10_1126_scitranslmed_adq5720
crossref_primary_10_1016_S2666_5247_23_00410_X
crossref_primary_10_1016_j_cell_2021_01_035
crossref_primary_10_1080_01913123_2022_2035475
crossref_primary_10_1038_s42003_021_02128_8
crossref_primary_10_1016_j_eclinm_2022_101323
crossref_primary_10_1016_j_jmb_2021_167177
crossref_primary_10_1038_s42003_022_03262_7
crossref_primary_10_1021_acs_jcim_3c01857
crossref_primary_10_1038_s41467_024_46536_w
crossref_primary_10_1126_scitranslmed_ado9026
crossref_primary_10_7554_eLife_82584
crossref_primary_10_1126_scitranslmed_abd1525
crossref_primary_10_1073_pnas_2404250121
crossref_primary_10_1098_rsfs_2021_0019
crossref_primary_10_1128_spectrum_01538_22
crossref_primary_10_3389_fimmu_2021_710263
crossref_primary_10_1038_s41467_024_47784_6
crossref_primary_10_1146_annurev_psych_032420_031329
crossref_primary_10_1126_scitranslmed_ade9984
crossref_primary_10_1038_s41586_023_06753_7
crossref_primary_10_1126_scitranslmed_abg1143
crossref_primary_10_3390_pathogens11020186
crossref_primary_10_1038_s41467_022_29416_z
crossref_primary_10_1038_s41586_022_04980_y
crossref_primary_10_1016_j_chom_2023_10_018
crossref_primary_10_1186_s12929_022_00852_9
crossref_primary_10_1073_pnas_2301518120
crossref_primary_10_3390_vaccines8040649
crossref_primary_10_1126_sciimmunol_abo3425
crossref_primary_10_1016_j_it_2020_09_004
crossref_primary_10_1016_j_bpj_2024_03_018
crossref_primary_10_1126_science_abh1766
crossref_primary_10_4269_ajtmh_22_0078
crossref_primary_10_1016_j_celrep_2022_110558
crossref_primary_10_1016_j_xcrm_2021_100354
crossref_primary_10_1016_j_xcrm_2022_100653
crossref_primary_10_1038_s42003_023_05649_6
crossref_primary_10_1038_s41564_022_01170_4
crossref_primary_10_1021_jacs_3c00291
crossref_primary_10_1371_journal_ppat_1009161
crossref_primary_10_1016_j_cell_2022_11_006
crossref_primary_10_1016_j_xcrm_2022_100651
crossref_primary_10_1111_irv_70076
crossref_primary_10_1016_j_celrep_2021_109452
crossref_primary_10_3390_v13112325
crossref_primary_10_1038_s41467_024_49656_5
crossref_primary_10_1126_science_abm3125
crossref_primary_10_3389_fimmu_2021_730051
crossref_primary_10_3389_fimmu_2024_1495561
crossref_primary_10_1016_j_cell_2021_02_035
crossref_primary_10_1021_acs_biochem_1c00139
crossref_primary_10_1016_j_isci_2021_102941
crossref_primary_10_1002_prot_26025
crossref_primary_10_1021_acsnano_2c07822
crossref_primary_10_1038_s41564_022_01235_4
crossref_primary_10_1038_s41467_024_46714_w
crossref_primary_10_1371_journal_pone_0261656
crossref_primary_10_1021_acs_jproteome_0c00654
crossref_primary_10_1172_JCI166844
crossref_primary_10_1021_acs_jproteome_0c00637
crossref_primary_10_1038_s41392_022_00910_6
crossref_primary_10_3390_v16030407
crossref_primary_10_1038_s41586_024_07636_1
crossref_primary_10_3390_biomedicines11061694
crossref_primary_10_1080_22221751_2024_2389095
crossref_primary_10_1016_j_it_2023_03_002
crossref_primary_10_1126_sciadv_abf1591
crossref_primary_10_1038_s41467_022_31005_z
crossref_primary_10_1038_s41590_024_01743_x
crossref_primary_10_1038_s41598_024_77336_3
crossref_primary_10_3390_vaccines11091506
crossref_primary_10_1128_jvi_00521_24
crossref_primary_10_1016_j_xcrm_2023_100971
crossref_primary_10_1126_science_abn8863
crossref_primary_10_3390_bioengineering10020148
crossref_primary_10_1128_jvi_01626_21
crossref_primary_10_1038_s41557_021_00758_3
crossref_primary_10_1038_s41586_021_03594_0
crossref_primary_10_3389_fpls_2023_1146234
crossref_primary_10_1038_s41421_022_00401_6
crossref_primary_10_1038_s41590_022_01351_7
crossref_primary_10_1038_s41423_023_01116_8
crossref_primary_10_7554_eLife_86764
crossref_primary_10_1002_jmv_27885
crossref_primary_10_1073_pnas_2214556120
crossref_primary_10_1016_j_immuni_2023_07_007
crossref_primary_10_1016_j_jbc_2021_100745
crossref_primary_10_1016_j_celrep_2021_110210
crossref_primary_10_1073_pnas_2403260121
Cites_doi 10.1128/JVI.77.16.8801-8811.2003
10.7554/eLife.51230
10.1016/j.cell.2018.12.028
10.1016/j.celrep.2019.08.052
10.1016/S0140-6736(20)30183-5
10.1038/nmeth.4169
10.1093/bioinformatics/btz671
10.1371/journal.ppat.1003618
10.1126/science.aav9033
10.1126/science.abb2507
10.1146/annurev-virology-110615-042301
10.1038/s41586-020-2012-7
10.1126/science.1243283
10.1038/ncomms9143
10.1038/s41592-019-0580-y
10.1038/s41467-017-01708-9
10.1073/pnas.1707304114
10.1126/science.aam7260
10.1083/jcb.141.6.1335
10.1073/pnas.1708727114
10.1107/S2059798319011471
10.1126/science.abb7269
10.1016/j.celrep.2018.03.061
10.1073/pnas.0403492101
10.1016/S0140-6736(20)30154-9
10.1128/JVI.00127-20
10.1128/JVI.78.12.6134-6142.2004
10.1016/j.celrep.2020.03.025
10.1016/j.cell.2020.02.058
10.1038/s41594-019-0334-7
10.1107/S0907444910007493
10.1107/S2059798318002425
10.1016/j.cell.2020.02.052
ContentType Journal Article
Copyright Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). 2020 The Authors
Copyright_xml – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
– notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
– notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). 2020 The Authors
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QF
7QG
7QL
7QP
7QQ
7QR
7SC
7SE
7SN
7SP
7SR
7SS
7T7
7TA
7TB
7TK
7TM
7U5
7U9
8BQ
8FD
C1K
F28
FR3
H8D
H8G
H94
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
M7N
P64
RC3
7X8
5PM
DOI 10.1126/science.abd0826
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Aluminium Industry Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Ceramic Abstracts
Chemoreception Abstracts
Computer and Information Systems Abstracts
Corrosion Abstracts
Ecology Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Materials Business File
Mechanical & Transportation Engineering Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Solid State and Superconductivity Abstracts
Virology and AIDS Abstracts
METADEX
Technology Research Database
Environmental Sciences and Pollution Management
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
Aerospace Database
Copper Technical Reference Library
AIDS and Cancer Research Abstracts
Materials Research Database
ProQuest Computer Science Collection
ProQuest Health & Medical Complete (Alumni)
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Technology Research Database
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
Nucleic Acids Abstracts
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
ProQuest Health & Medical Complete (Alumni)
Materials Business File
Environmental Sciences and Pollution Management
Aerospace Database
Copper Technical Reference Library
Engineered Materials Abstracts
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Advanced Technologies Database with Aerospace
ANTE: Abstracts in New Technology & Engineering
Civil Engineering Abstracts
Aluminium Industry Abstracts
Virology and AIDS Abstracts
Electronics & Communications Abstracts
Ceramic Abstracts
Ecology Abstracts
Neurosciences Abstracts
METADEX
Biotechnology and BioEngineering Abstracts
Computer and Information Systems Abstracts Professional
Entomology Abstracts
Animal Behavior Abstracts
Solid State and Superconductivity Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Corrosion Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Materials Research Database
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Biology
EISSN 1095-9203
EndPage 1505
ExternalDocumentID PMC7402631
32703906
10_1126_science_abd0826
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R01 GM120554
– fundername: NIGMS NIH HHS
  grantid: R01 GM124141
– fundername: NIAID NIH HHS
  grantid: R01 AI127521
– fundername: NIAID NIH HHS
  grantid: 75N93019C00050
– fundername: NIAID NIH HHS
  grantid: R01 AI122753
– fundername: ;
  grantid: 1453358
– fundername: ;
  grantid: AI122753
– fundername: ;
  grantid: R01-AI127521
– fundername: ;
  grantid: GM124141
– fundername: ;
  grantid: GM120554
– fundername: ;
  grantid: F-1808
– fundername: ;
  grantid: F-1767
GroupedDBID ---
--Z
-DZ
-ET
-~X
.-4
..I
.55
.DC
08G
0R~
0WA
123
18M
2FS
2KS
2WC
2XV
34G
36B
39C
3R3
53G
5RE
66.
6OB
6TJ
7X2
7~K
85S
8F7
AABCJ
AACGO
AAIKC
AAMNW
AANCE
AAWTO
AAYXX
ABCQX
ABDBF
ABDEX
ABDQB
ABEFU
ABIVO
ABJNI
ABOCM
ABPLY
ABPPZ
ABQIJ
ABTLG
ABWJO
ABZEH
ACBEA
ACBEC
ACGFO
ACGFS
ACGOD
ACIWK
ACMJI
ACNCT
ACPRK
ACQOY
ACUHS
ADDRP
ADUKH
ADXHL
AEGBM
AENEX
AETEA
AFBNE
AFFNX
AFHKK
AFQFN
AFRAH
AGFXO
AGNAY
AGSOS
AHMBA
AIDAL
AIDUJ
AJGZS
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ASPBG
AVWKF
BKF
BLC
C45
CITATION
CS3
DB2
DU5
EBS
EMOBN
F5P
FA8
FEDTE
HZ~
I.T
IAO
IEA
IGS
IH2
IHR
INH
INR
IOF
IOV
IPO
IPY
ISE
JCF
JLS
JSG
JST
K-O
KCC
L7B
LSO
LU7
M0P
MQT
MVM
N9A
NEJ
NHB
O9-
OCB
OFXIZ
OGEVE
OMK
OVD
P-O
P2P
PQQKQ
PZZ
RHI
RXW
SC5
SJN
TAE
TEORI
TN5
TWZ
UBW
UCV
UHB
UKR
UMD
UNMZH
UQL
USG
VVN
WH7
WI4
X7M
XJF
XZL
Y6R
YK4
YKV
YNT
YOJ
YR2
YR5
YRY
YSQ
YV5
YWH
YYP
YZZ
ZCA
ZE2
~02
~G0
~KM
~ZZ
0B8
AEUPB
CGR
CUY
CVF
ECM
EIF
ESX
GX1
IGG
NPM
OK1
PKN
RHF
UIG
VQA
YCJ
YIF
YIN
7QF
7QG
7QL
7QP
7QQ
7QR
7SC
7SE
7SN
7SP
7SR
7SS
7T7
7TA
7TB
7TK
7TM
7U5
7U9
8BQ
8FD
C1K
F28
FR3
H8D
H8G
H94
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c515t-c5ca568d7fde90ea0a33eee540d3f659b04c34a2e9f58cd6343361d00cfd242c3
ISSN 0036-8075
1095-9203
IngestDate Thu Aug 21 14:31:07 EDT 2025
Thu Jul 10 19:34:40 EDT 2025
Fri Jul 25 10:50:33 EDT 2025
Wed Feb 19 02:08:41 EST 2025
Tue Jul 01 01:35:16 EDT 2025
Thu Apr 24 23:09:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6510
Language English
License https://creativecommons.org/licenses/by/4.0
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c515t-c5ca568d7fde90ea0a33eee540d3f659b04c34a2e9f58cd6343361d00cfd242c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0626-8094
0000-0001-6044-1332
0000-0003-3991-542X
0000-0002-0363-8486
0000-0003-4351-125X
0000-0003-1268-7164
0000-0001-9549-4645
0000-0002-6462-8951
0000-0002-7565-7002
0000-0002-9371-2431
0000-0001-9618-338X
0000-0001-5098-7737
0000-0001-5705-3259
0000-0002-0538-9647
0000-0002-3665-5717
0000-0002-1130-2675
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7402631
PMID 32703906
PQID 2426572246
PQPubID 1256
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7402631
proquest_miscellaneous_2427305953
proquest_journals_2426572246
pubmed_primary_32703906
crossref_citationtrail_10_1126_science_abd0826
crossref_primary_10_1126_science_abd0826
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-09-18
PublicationDateYYYYMMDD 2020-09-18
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-18
  day: 18
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Science (American Association for the Advancement of Science)
PublicationTitleAlternate Science
PublicationYear 2020
Publisher The American Association for the Advancement of Science
American Association for the Advancement of Science
Publisher_xml – name: The American Association for the Advancement of Science
– name: American Association for the Advancement of Science
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
Ramírez-Aportela E. (e_1_3_2_31_2) 2020; 36
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
32577660 - bioRxiv. 2020 May 30
References_xml – ident: e_1_3_2_8_2
  doi: 10.1128/JVI.77.16.8801-8811.2003
– ident: e_1_3_2_16_2
  doi: 10.7554/eLife.51230
– ident: e_1_3_2_18_2
  doi: 10.1016/j.cell.2018.12.028
– ident: e_1_3_2_17_2
  doi: 10.1016/j.celrep.2019.08.052
– ident: e_1_3_2_3_2
  doi: 10.1016/S0140-6736(20)30183-5
– ident: e_1_3_2_30_2
  doi: 10.1038/nmeth.4169
– volume: 36
  start-page: 765
  year: 2020
  ident: e_1_3_2_31_2
  article-title: Automatic local resolution-based sharpening of cryo-EM maps
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btz671
– ident: e_1_3_2_13_2
  doi: 10.1371/journal.ppat.1003618
– ident: e_1_3_2_14_2
  doi: 10.1126/science.aav9033
– ident: e_1_3_2_19_2
  doi: 10.1126/science.abb2507
– ident: e_1_3_2_4_2
  doi: 10.1146/annurev-virology-110615-042301
– ident: e_1_3_2_7_2
  doi: 10.1038/s41586-020-2012-7
– ident: e_1_3_2_21_2
  doi: 10.1126/science.1243283
– ident: e_1_3_2_23_2
  doi: 10.1038/ncomms9143
– ident: e_1_3_2_29_2
  doi: 10.1038/s41592-019-0580-y
– ident: e_1_3_2_25_2
  doi: 10.1038/s41467-017-01708-9
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.1707304114
– ident: e_1_3_2_27_2
  doi: 10.1126/science.aam7260
– ident: e_1_3_2_26_2
  doi: 10.1083/jcb.141.6.1335
– ident: e_1_3_2_9_2
  doi: 10.1073/pnas.1708727114
– ident: e_1_3_2_33_2
  doi: 10.1107/S2059798319011471
– ident: e_1_3_2_28_2
  doi: 10.1126/science.abb7269
– ident: e_1_3_2_22_2
  doi: 10.1016/j.celrep.2018.03.061
– ident: e_1_3_2_10_2
  doi: 10.1073/pnas.0403492101
– ident: e_1_3_2_2_2
  doi: 10.1016/S0140-6736(20)30154-9
– ident: e_1_3_2_6_2
  doi: 10.1128/JVI.00127-20
– ident: e_1_3_2_11_2
  doi: 10.1128/JVI.78.12.6134-6142.2004
– ident: e_1_3_2_24_2
  doi: 10.1016/j.celrep.2020.03.025
– ident: e_1_3_2_20_2
  doi: 10.1016/j.cell.2020.02.058
– ident: e_1_3_2_15_2
  doi: 10.1038/s41594-019-0334-7
– ident: e_1_3_2_32_2
  doi: 10.1107/S0907444910007493
– ident: e_1_3_2_34_2
  doi: 10.1107/S2059798318002425
– ident: e_1_3_2_5_2
  doi: 10.1016/j.cell.2020.02.052
– reference: 32577660 - bioRxiv. 2020 May 30;:
SSID ssj0009593
Score 2.7265658
Snippet The development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein...
The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the...
Stabilizing the prefusion SARS-CoV-2 spikeThe development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2...
The COVID-19 pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1501
SubjectTerms Amino Acid Substitution
Antibodies
Betacoronavirus - chemistry
Biochem
Coronaviridae
Coronavirus Infections - prevention & control
Coronaviruses
COVID-19
COVID-19 Vaccines
Cryoelectron Microscopy
Freeze thaw cycles
Freeze-thaw durability
Freeze-thawing
Freezing
Heat stress
Heat tolerance
Humans
Pandemics
Proline
Proline - chemistry
Protein Domains
Protein Stability
Proteins
Respiratory diseases
Room temperature
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Spike Glycoprotein, Coronavirus - chemistry
Vaccines
Viral diseases
Viral Vaccines - chemistry
Virology
Title Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
URI https://www.ncbi.nlm.nih.gov/pubmed/32703906
https://www.proquest.com/docview/2426572246
https://www.proquest.com/docview/2427305953
https://pubmed.ncbi.nlm.nih.gov/PMC7402631
Volume 369
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6CTki8IDZuHQMFiYehyZVrx07yRrZRlduEaIf2FiW2IyamdKLtA_v1HMdOmo4OMV6s1rGTyN-xz2fnXABeDyNeCqo5QSoakpCZhBQ5VaROjcSYodJY3-HPJ3J8Gn44E2cr-_nau2RRDNTVRr-S_0EV6xBX6yV7C2Tbm2IF_kZ8sUSEsfwnjCd18NflT0OsMtIHujbHqI2YUfEt7UEYQfZn7V-vLLFMv07I0ewbYQfzy_Mf3nrQM9NmkiPjbL_idLBrzRFTZzTQ2BD4bs2Bgj8_wM2izX8Qt4hPVw4st7ltd031IY2dRnHLKLUZIBnl3XWWu5wsXqCk8OasbuFEXjrsKGH8KzYv8J2UlGaQFxopzIZQ2uN0kn05HmWf3p98vAtbDPcQrAdb6eHx4ejGmMw-8lPHp6p5wDpp-WMnct2gtsNQpg_hgd9aBKmTk224Y6oduOeSjf7agW0_pvNg38caf_MI3l4TocCJUDArg00iFKxEKHAi9BhOR--mR2Pik2oQhdR1gaXKhYx1VGqTUJPTnHNjDBJ3zUspkoKGioc5TtpSxEpLHnIuh5pSVWqkc4o_gV41q8wzCAyNVBQpTYtYhkicY0WVtXVkZVJiZdiHQTNqmfIR523ik4us3nkymflhzvww92G_7XDpgq3c3HSvgSHzM3KeWbopIhsisQ-v2su4XtqPYHllZsu6DSo1kQjeh6cOtfZZnKH-Syj2jtbwbBvYWOzrV6rz73VM9iikTPLh7t9f6zncX03BPeghxOYFktpF8dIL52-A_KZw
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure-based+design+of+prefusion-stabilized+SARS-CoV-2+spikes&rft.jtitle=Science+%28American+Association+for+the+Advancement+of+Science%29&rft.date=2020-09-18&rft.pub=The+American+Association+for+the+Advancement+of+Science&rft.issn=0036-8075&rft.eissn=1095-9203&rft.volume=369&rft.issue=6510&rft.spage=1501&rft.epage=1505&rft_id=info:doi/10.1126%2Fscience.abd0826&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-8075&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-8075&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-8075&client=summon